of following key factors: 1. Revenue from sales of electricity were THB 173 million in the third quarter of 2020, which increased by THB 81 million or 89% from the same period last year. The increase
17.74% 20.03 9.21% 49.42 246.73% Jul – Sep 63 Jul – Sep 62 Increase/(Decrease) DOD BIOTECH PUBLIC COMPANY LIMITED เลขที่ 111 หมู่ที่ 2 ตาํบลท่าจนี อาํเภอเมืองสมุทรสาคร จงัหวดัสมุทรสาคร 74000 111 Moo 2
Company, wishes to raise funds through an increase of its registered capital and offer such newly issued ordinary shares to the public by an initial public offering (the “IPO”) and subsequently list its
early 2018. - OSP energy drink market share was at 54%. Q4’18 M150 market share was at 37.9% increase by 90bps QOQ. C-Vitt took over leadership position in functional drink market, with Q4’18 market share
. 2Q 2019 PERFORMANCE ANALYSIS (YoY) In 2Q 2019, the Company reported a consolidated operating revenue of THB 690mn, a significant increase of 161.5% YoY from THB 264mn in 2Q 2018. The revenue comprised
additional provision of THB 20 Million due to increase in the benefit of employees who have past service of 20 years or more from 300 days to 400 days according to the announcement of Labour Protection Act
7,930.03 8,296.77 Increase (Decrease) % Quarter 2 The operating result according to the consolidated financial statement for the 2 nd quarter of 2019 showed the profit (attributable to owners of the Company
Limited (“the Company”) had methyl ester sales volume at 101,371 tons, an increase of 22,346 tons or 28% compared to 1Q2019. This comparison excluded methyl ester sales volume in 1Q2019 of 15,678 tons which
has introduced relief measures to boost the economy and increase liquidity to alleviate the impact of COVID-19 on citizens and businesses. In response to the crisis, the government has introduced cash
increase of revenue from office segment and management income • EBITDA stood at THB (93)mn, largely from the shortfall of revenue, partially relieved by lower operating costs and selling and administrative